155 related articles for article (PubMed ID: 34986465)
1. Biophysical and biochemical attributes of hybrid epithelial/mesenchymal phenotypes.
Subbalakshmi AR; Ashraf B; Jolly MK
Phys Biol; 2022 Feb; 19(2):. PubMed ID: 34986465
[TBL] [Abstract][Full Text] [Related]
2. Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression.
Sinha D; Saha P; Samanta A; Bishayee A
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33207810
[TBL] [Abstract][Full Text] [Related]
3. Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas.
Jolly MK; Somarelli JA; Sheth M; Biddle A; Tripathi SC; Armstrong AJ; Hanash SM; Bapat SA; Rangarajan A; Levine H
Pharmacol Ther; 2019 Feb; 194():161-184. PubMed ID: 30268772
[TBL] [Abstract][Full Text] [Related]
4. A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT).
Subbalakshmi AR; Sahoo S; Biswas K; Jolly MK
Cells Tissues Organs; 2022; 211(6):689-702. PubMed ID: 33567424
[TBL] [Abstract][Full Text] [Related]
5. Stability of the hybrid epithelial/mesenchymal phenotype.
Jolly MK; Tripathi SC; Jia D; Mooney SM; Celiktas M; Hanash SM; Mani SA; Pienta KJ; Ben-Jacob E; Levine H
Oncotarget; 2016 May; 7(19):27067-84. PubMed ID: 27008704
[TBL] [Abstract][Full Text] [Related]
6. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype.
Subbalakshmi AR; Kundnani D; Biswas K; Ghosh A; Hanash SM; Tripathi SC; Jolly MK
Front Oncol; 2020; 10():553342. PubMed ID: 33014880
[TBL] [Abstract][Full Text] [Related]
7. Hybrid epithelial/mesenchymal phenotype(s): The 'fittest' for metastasis?
Jolly MK; Mani SA; Levine H
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):151-157. PubMed ID: 29997040
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive Traits of the Hybrid Epithelial/Mesenchymal Phenotype.
Sahoo S; Nayak SP; Hari K; Purkait P; Mandal S; Kishore A; Levine H; Jolly MK
Front Immunol; 2021; 12():797261. PubMed ID: 34975907
[TBL] [Abstract][Full Text] [Related]
9. A Biophysical Model Uncovers the Size Distribution of Migrating Cell Clusters across Cancer Types.
Bocci F; Kumar Jolly M; Onuchic JN
Cancer Res; 2019 Nov; 79(21):5527-5535. PubMed ID: 31481500
[TBL] [Abstract][Full Text] [Related]
10. Numb prevents a complete epithelial-mesenchymal transition by modulating Notch signalling.
Bocci F; Jolly MK; Tripathi SC; Aguilar M; Hanash SM; Levine H; Onuchic JN
J R Soc Interface; 2017 Nov; 14(136):. PubMed ID: 29187638
[TBL] [Abstract][Full Text] [Related]
11. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis.
Jolly MK; Boareto M; Huang B; Jia D; Lu M; Ben-Jacob E; Onuchic JN; Levine H
Front Oncol; 2015; 5():155. PubMed ID: 26258068
[TBL] [Abstract][Full Text] [Related]
12. Network topology metrics explaining enrichment of hybrid epithelial/mesenchymal phenotypes in metastasis.
Rashid M; Hari K; Thampi J; Santhosh NK; Jolly MK
PLoS Comput Biol; 2022 Nov; 18(11):e1010687. PubMed ID: 36346808
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer.
Sample RA; Nogueira MF; Mitra RD; Puram SV
Oncogene; 2023 Jul; 42(29):2237-2248. PubMed ID: 37344626
[TBL] [Abstract][Full Text] [Related]
14. Epithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?
Jolly MK; Tripathi SC; Somarelli JA; Hanash SM; Levine H
Mol Oncol; 2017 Jul; 11(7):739-754. PubMed ID: 28548388
[TBL] [Abstract][Full Text] [Related]
15. Hybrid Epithelial-Mesenchymal Phenotypes Are Controlled by Microenvironmental Factors.
Selvaggio G; Canato S; Pawar A; Monteiro PT; Guerreiro PS; BrĂ¡s MM; Janody F; Chaouiya C
Cancer Res; 2020 Jun; 80(11):2407-2420. PubMed ID: 32217696
[TBL] [Abstract][Full Text] [Related]
16. OVOL guides the epithelial-hybrid-mesenchymal transition.
Jia D; Jolly MK; Boareto M; Parsana P; Mooney SM; Pienta KJ; Levine H; Ben-Jacob E
Oncotarget; 2015 Jun; 6(17):15436-48. PubMed ID: 25944618
[TBL] [Abstract][Full Text] [Related]
17. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
18. Involvement of partial EMT in cancer progression.
Saitoh M
J Biochem; 2018 Oct; 164(4):257-264. PubMed ID: 29726955
[TBL] [Abstract][Full Text] [Related]
19. Modeling of mesenchymal hybrid epithelial state and phenotypic transitions in EMT and MET processes of cancer cells.
He P; Qiu K; Jia Y
Sci Rep; 2018 Sep; 8(1):14323. PubMed ID: 30254295
[TBL] [Abstract][Full Text] [Related]
20. Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis.
Huang B; Jolly MK; Lu M; Tsarfaty I; Ben-Jacob E; Onuchic JN
Sci Rep; 2015 Dec; 5():17379. PubMed ID: 26627083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]